Literature DB >> 20569706

Real-world outcome from ST elevation myocardial infarction in the very elderly before and after the introduction of a 24/7 primary percutaneous coronary intervention service.

Rhidian J Shelton1, Andrew M Crean, Kathryn Somers, Claire Priestley, Carol Hague, Jonathan M Blaxill, Stephen B Wheatcroft, James M McLenachan, John P Greenwood, Daniel J Blackman.   

Abstract

BACKGROUND: It remains unclear whether the superiority of primary percutaneous coronary intervention (PPCI) over thrombolysis for the treatment of ST elevation myocardial infarction (STEMI) extends to the very elderly. Furthermore, the deliverability and efficacy of PPCI in over the 80s has not been investigated in a real-world setting. The aim of this study was to compare outcome from STEMI in patients aged > or =80 before and after the introduction of routine 24/7 PPCI.
METHODS: Retrospective observational analysis of all patients aged > or =80 presenting with STEMI to 2 neighboring hospitals in the 3-year period after the introduction of a 24/7 PPCI service and in the preceding 2 years when reperfusion therapy was by thrombolysis.
RESULTS: Two hundred fifty-six STEMI patients aged > or =80 were included. After the introduction of PPCI, 84% (136/161) received reperfusion therapy, 73% PPCI, and 12% thrombolysis, compared to 77% ([73/95] 1% PPCI, 76% thrombolysis) previously. Mortality after inception of PPCI was reduced at 12 months (29% vs 41%, P = .04) and 3 years (43% vs 58%, P = .02). Improved outcome was attributable to treatment by PPCI, which was associated with numerically lower 12-month (26% vs 37%, P = .07) and significantly reduced 3-year (42% vs 55%, P = .05) mortality compared to thrombolysis.
CONCLUSIONS: Primary PCI can be effectively delivered to very elderly patients presenting with ST elevation MI in a real-world setting and leads to a substantial reduction in mortality compared to patients treated by thrombolysis. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20569706     DOI: 10.1016/j.ahj.2010.02.026

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

1.  Reperfusion therapy and mortality in octogenarian STEMI patients: results from the Belgian STEMI registry.

Authors:  Els H Vandecasteele; Marc De Buyzere; Sofie Gevaert; Antoine de Meester; Carl Convens; Philippe Dubois; Jean Boland; Peter Sinnaeve; Herbert De Raedt; Pascal Vranckx; Patrick Coussement; Patrick Evrard; Christophe Beauloye; Marc Renard; Marc J Claeys
Journal:  Clin Res Cardiol       Date:  2013-07-26       Impact factor: 5.460

2.  Predictors of the early outcome in elderly patients with ST elevation myocardial infarction treated with primary angioplasty: a single center experience.

Authors:  Chiara Lazzeri; Serafina Valente; Marco Chiostri; Claudio Picariello; Gian Franco Gensini
Journal:  Intern Emerg Med       Date:  2010-09-18       Impact factor: 3.397

3.  Age-related treatment strategy and long-term outcome in acute myocardial infarction patients in the PCI era.

Authors:  Petr Kala; Jan Kanovsky; Richard Rokyta; Michal Smid; Jan Pospisil; Jiri Knot; Filip Rohac; Martin Poloczek; Tomas Ondrus; Maria Holicka; Jindrich Spinar; Jiri Jarkovsky; Ladislav Dusek
Journal:  BMC Cardiovasc Disord       Date:  2012-04-25       Impact factor: 2.298

4.  The Comparison of the Outcomes between Primary PCI, Fibrinolysis, and No Reperfusion in Patients ≥ 75 Years Old with ST-Segment Elevation Myocardial Infarction: Results from the Chinese Acute Myocardial Infarction (CAMI) Registry.

Authors:  He Peiyuan; Yang Jingang; Xu Haiyan; Gao Xiaojin; Xian Ying; Wu Yuan; Li Wei; Wang Yang; Tang Xinran; Yan Ruohua; Jin Chen; Song Lei; Zhang Xuan; Fu Rui; Ye Yunqing; Dong Qiuting; Sun Hui; Yan Xinxin; Gao Runlin; Yang Yuejin
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

5.  Effectiveness of percutaneous coronary intervention within 12 hours to 28 days of ST-elevation myocardial infarction in a real-world Chinese population.

Authors:  Xingli Wu; Dingyou Yang; Yusheng Zhao; Caiyi Lu; Yu Wang
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.